Due to a lack of health equity and many existing health disparities for rare disease patients, their access to clinical trial participation is often greatly diminished. With limited education and finances, many do not know about trial opportunities, while others cannot fathom the additional costs of participating.
Health IT Issues recently cited Clincierge CEO Scott Gray‘s article Modernizing Clinical Trials in 2023 with Patient Centricity as one of the most-read thought leader posts for December 2022.
Clincierge CEO Scott Gray shares his experiences and best practices for providing patient concierge support services to pediatric clinical trial patients and their caregivers in this new Clinical Research News article.
In this Drug Discovery World article, author Megan Thomas spoke with decision makers from the clinical trial industry, including Clincierge’s CEO, Scott Gray, about their predictions on what 2022 holds for our sector, including the importance of patient-centricity and improved stakeholder engagement in clinical trials.
In this Health IT Answers article, Scott Gray, CEO, discusses modern patient-centric methods to remove barriers and increase access in rare disease clinical trials, such as prioritizing patient engagement, embracing digital solutions, and investing in supplemental patient support services.
Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.
Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings …
Amplifying the Voice of the Patient in Rare Disease Trials Read More »
In this SCRS Talks podcast, Scott Gray, CEO, highlights statistics from an independent, IRB-approved survey of patients and caregivers regarding participation in clinical trials. Learn about the financial risks of patient dropouts and trial delays, plus practical strategies for making trial participation easier and encouraging patient retention.
Featured in Clinical Researcher: Scott Gray, CEO, discusses the business case for patient experience, including the patient’s role in clinical trial return on investment (ROI), the benefits of patient centricity, and investing in patient experience.
September is Newborn Screening Awareness Month. Since the 1960s, every infant born in America receives a heel prick within the first 48 hours of life. The dried blood is then tested for various genetic, endocrine, and metabolic disorders. When the test detects a specific disease, families are educated, and a life-changing treatment plan is quickly …
Newborn Screening Awareness Month: Advances Toward a Federalized Screening Program Read More »
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
